Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients

BACKGROUND: Hepatitis E virus (HEV) may be resistant to immunosuppression reduction and ribavirin treatment in kidney transplant recipients because of mutant strains and severe side effects of ribavirin which conduct to dose reduction. Sofosbuvir efficacy is controversial. Peg-interferon 2 alpha (PE...

Descripción completa

Detalles Bibliográficos
Autores principales: Ollivier-Hourmand, I., Lebedel, L., Lecouf, A., Allaire, M., Nguyen, T. T. N., Lier, C., Dao, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367388/
https://www.ncbi.nlm.nih.gov/pubmed/32677900
http://dx.doi.org/10.1186/s12879-020-05212-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367388/
https://www.ncbi.nlm.nih.gov/pubmed/32677900
http://dx.doi.org/10.1186/s12879-020-05212-2

Ejemplares similares